Medical Case Management Services Market is Estimated to be Valued at US$ 5.1 Billion by 2021

According to the latest market report published by Persistence Market Research titled “Global Market Study on Medical Case Management Services: Rising Demand for Medical Tourism is Expected to Boost the Growth of Medical Case Management Services?”, the global medical case management services market is projected to expand at a CAGR of 3.0% during the forecast period (2015 – 2021).

Medical case management services help reduce medical healthcare cost of patients. This is because this service provides options for patients to select the best or most cost-effective medical plan offered by medical providers and ensures that patients get timely and proper medical care at an appropriate medical center. The global medical case management services market was valued at US$ 4,200 Mn in 2014 and is expected to increase to US$ 5,155.1 Mn by 2021, expanding at a CAGR of 3.0% over the forecast period.

Private and public healthcare expenditure is rising globally, with increasing population and prevalence of various diseases. Also, changing lifestyle is responsible for the escalating demand for advanced healthcare products and services.

The report analyses the global medical case management services market in terms of market value (US$ Mn), by mode of service, the severity of the case, and end user, and provides information regarding regional market dynamics, regulations, competitive landscape, current trends, market estimations, and forecast.

Globally, North America is expected to dominate the market throughout the forecast period, driven by the rise in healthcare expenditure, technological advancements, and increase in the prevalence of chronic diseases and injuries. The medical case management services market in North America is expected to increase from its current estimated value of US$ 3,021.6 Mn in 2015 to US$ 3,586.5 Mn by 2021, expanding at a CAGR of 2.9% over the forecast period. Demand for medical case management services is expected to grow continuously over the forecast period due to improvement in employment levels, especially in developed countries. This is likely to further drive demand for case managers in the advent of workplace injuries, as an increasing number of companies are offering employees optional cover under various medical or healthcare schemes. Europe is the subsequent lucrative destination for the medical case management services providers.

Among the various mode of service segments, the medical case management services market finds maximum opportunity in the telephonic case management service, followed by web-based case management services. The bilingual field case management service segment is expected to gain traction in the near future due to increasing demand for medical tourism globally. Players in this market are continuously introducing newer services to enhance their service portfolio and to cater to client requirements or necessity. Medical case managers are adopting different technologies such as electronic health records, predictive modeling tools, Internet-based education and communication tools, etc. to monitor patients’ clinical history and have better access to client information. This allows for a faster and more accurate advice and diagnosis. The client also gains access to their own information to get an understanding of their current health status.

By severity of the case, the global medical case management services market is segmented into catastrophic case management, chronic pain case management, independent medical examinations, long-term disability and, short-term disability. The long-term disability segment is expected to dominate the overall medical case management services market by the end of the forecast period, i.e. by 2021. The independent medical case management segment is expected to expand at the fastest CAGR of 3.6% over the forecast period.

A Sample of this report is available upon request @ www.persistencemarketresearch.com/samples/5294

Key market participants covered in the report include GENEX Services Inc., Europ Assistance – Global Corporate Solutions, EagleOne Case Management Solutions, Inc., Medical Case Management Group, EK Health Services Inc., Axiom Medical Consulting, LLC, Managed Medical Review Organization Inc., Healthcare Solutions Inc., and Precyse Solutions LLC.

To Buy Full Report for a Single User @ www.persistencemarketresearch.com/checkout/5294

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us

Persistence Market Research

305 Broadway

7th Floor, New York City,

NY 10007, United States,

USA – Canada Toll Free: 800-961-0353

Email: sales@persistencemarketresearch.com

Web: http://www.persistencemarketresearch.com

Advertisements

Surgical and Respirator Masks Market in Australia and New Zealand is Anticipated to Grow US$ 167.7 Million by 2021

According to a new market report published by Persistence Market Research, titled “Australia and New Zealand Market Study on Surgical and Respirator Masks: Australia to Witness Highest Growth by 2021”, the surgical and respiratory mask market in Australia and New Zealand is expected to reach US$137.8 Mn by the end of 2015 and is anticipated to expand at a CAGR of 3.3% from 2015 to 2021, to reach US$167.7 Mn by 2021.
Surgical and respiratory masks can be defined as medical devices that are used to cover mouth, nose and chin, in order to protect the healthcare professionals and patients against droplets, including large respiratory particles. Surgical and respiratory masks are mainly used in hospitals and day surgery centres by physicians, independent dental surgeons, veterinary surgeons and life science professionals.
Presently, the surgical and respiratory mask market in Australia and New Zealand is mainly driven by factors such as the increasing number of surgical procedures, rising health and hygiene concerns, and product innovation. However, factors such as logistics and distribution channel formulation saturated the market with unmet consumer needs, limited product availability, and competition between large multinational and local players are expected to restrain the growth of the market. The surgical and respiratory mask market in Australia and New Zealand is anticipated to expand at a CAGR of 3.3 % from 2015 to 2021, to reach US$ 167.7 Mn by 2021.

A Sample of this report is available upon request @ http://www.persistencemarketresearch.com/samples/5684

The Australia surgical and respirator mask market is expected to dominate the entire market in Australia and New Zealand by the end of 2015. The market is expected to be valued atUS$ 106.2 Mn by the end of 2015. The surgical and respirator mask market in New Zealand is expected to be valued at US$ 31.6 Man by the end of 2015 and is expected to expand at a CAGR of 3.2% during the forecast period.

Request to view Table of content @ http://www.persistencemarketresearch.com/market-research/australia-new-zealand-surgical-respirator-masks-market/toc

Key players in the surgical and respiratory mask market in Australia and New Zealand include 3M Company, Smith & Nephew Plc., MölnlyckeHealthcare Inc., Medline Industries, Halyard Healthcare Inc. and Ansell Healthcare LLC.

To Buy Full Report for a Single User @ http://www.persistencemarketresearch.com/checkout/5684

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

 

Global Dental Implants Market to Spread a Predictable Worth of US$ 7,879.5 Million by 2020

According to a new market report published by Persistence Market Research “Global Market Study on Dental Implants – Asia Pacific to Witness Fastest Growth by 2020,” the global Dental implants market was valued at USD 4,508.9 million in 2014 and is expected to grow at a CAGR of 9.7% from 2014 to 2020, to reach an estimated value of USD 7,879.5 million in 2020.

Globally, rising aging population has increases the demand for dental implants in the market. As a result, the market is expected to grow at a CAGR of about 9.7% from 2014 – 2020.

Some of the major drivers which help in increasing demand for dental implants are rising aging population and growing concern for oral healthcare. Rising demand for cosmetic dentistry also supports the growth of dental implants market. High cost of dental implants surgery in countries such as the U.S. and the U.K. supports the growth of medical tourism in different part of the world including Malaysia, Hungary, Costa Rica, and India. However, limited reimbursements for dental implants surgery are restraining the growth of the dental implants market. Various technological advancements in dental implants such as Computer Aided Design (CAD), 3D imaging, mini dental implants, laser dentistry, sedation dentistry, and nanotechnology have improved dental surgical procedures.

Europe is the largest market for the global dental implants due to growing concern for oral hygiene, increasing clinical adoption of dental implants therapy and technological advancements. Some of the fastest growing markets for dental implants in Europe are the U.K., France and Germany. Titanium implants is the largest material based market and is expected to grow at a CAGR of about 9.8% from 2014 to 2020.

The dental implants market in North America is expected to witness moderate growth attributed to aging population, rising awareness about oral health and technological advancement in dental implants surgery procedures. Adoption of advanced dentistry by North American people also plays important roles in driving the growth of the dental implants market. According to the American Dental Hygienists’ Association (ADHA), approximately 75% of American adults were suffering from various forms of gum diseases in 2008. However, Asia Pacific is the fastest growing dental implants market. Growing concern about oral health and medical tourism are some factors driving the growth of the dental implant in the Asia Pacific market.

A Sample of this report is available upon request @ http://www.persistencemarketresearch.com/samples/2821

Institut Straumann AG is one of the leading players in the dental implants market. Other major players of dental implants market include Nobel Biocare, DENTSPLY International Inc. and Zimmer dental Inc., 3M Company and Neoss International.

To Buy Full Report for a Single User @ http://www.persistencemarketresearch.com/checkout/2821

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Global Clinical Trial Management System Market will hit at a CAGR of 14% by 2019

According to a new market report published by Persistence Market Research “Global Market Study on Clinical Trial Management System: Asia to Witness Highest Growth by 2019” the global clinical trial management system market was valued at USD 844.0 million in 2013 and is expected to grow at a CAGR of 14% from 2014 to 2019, to reach an estimated value of USD 1,848.5 million in 2019.

 Clinical trial is a medical research study performed on humans to check the safety and efficacy of drugs, devices and therapeutic products before they are finally launched in the market. Globally, the CTMS market is witnessing significant growth due to increasing R&D investment in pharmaceutical, life science and clinical research industries. It empowers organizations and research centers to enhance productivity and effectiveness of clinical trials by advancing and managing clinical trials. Integration of CTMS with hospital information system (HIS) provides more accurate and time saving documentation is also driving growth for the CTMS market. Additionally, increasing prevalence of diseases is supporting clinical trials in different regions, and increased clinical research outsourcing is playing a major role in the growth of the CTMS market. Increasing regulatory requirements in many countries has resulted in increased complexity for clinical trial protocols. Presence of various end users such as pharmaceuticals, clinical research organizations (CRO) and healthcare providers has increased the acceptance of CTMS. The global CTMS market was estimated to be USD 844 million in 2013. It is likely to grow at a CAGR of 14% during 2013 to 2019 to reach USD 1,848.5 million in 2019.

North America is a traditional clinical trial region. Due to regulatory and legal considerations and the clinical trial market has shifted from North America to developing countries such as India and China. Clinical trials in the U.S. have been funded and sponsored by National Institute of Health (NIH), other government agencies, academic groups, voluntary health organizations and industry.

In Europe, countries in Central and Eastern Europe provide abundant chance to life science companies for clinical development. Due to governmental support and funding for biomedical sciences, Germany has become a preferred location for clinical trials.

However, Asia is the fastest growing region in the clinical trial management system market.. Improved industry regulatory laws and patent expiration laws in various countries including Japan, China and India, have led to the expansion of the clinical trials market in Asia. Asia has lower cost of conducting clinical trials compared to Europe or the U.S.

A Sample of this report is available upon request @ http://www.persistencemarketresearch.com/samples/3017

Some of the major players in the CTMS market are Oracle Corporation, Bio-Optronics, MedNet Solutions, PAREXEL International Corporation, Medidata Solutions and BioClinica

To Buy Full Report for a Single User @ http://www.persistencemarketresearch.com/checkout/3017

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us

Persistence Market Research

305 Broadway

7th Floor, New York City,

NY 10007, United States,

USA – Canada Toll Free: 800-961-0353

Email: sales@persistencemarketresearch.com

Web: http://www.persistencemarketresearch.com

Extracorporeal Blood Treatment Market : Key Players, Growth and Analysis by 2017 – 2025

Blood purification has always been viewed as a branch of medicine which is extremely crucial and complicated. In 1950’s after the breakthrough of clinical dialysis different manufacturers invested in latest technologies and started as a supplier of extracorporeal blood treatment. The extracorporeal blood treatment is a type of filtration method used to remove many toxins from the blood. By the end of 1960’s, a company named B Braun started to manufacture its own dialysis machine. As the number of manufacturers increased, the use of these dialysis machines brought upon patient safety issues. In the 1980’s extracorporeal blood treatment systems became significantly user-friendly as there was more and more digitalization in these systems.

A Sample of this Report is Available Upon Request @ www.persistencemarketresearch.com/samples/15685

Extracorporeal Blood Treatment Market: Drivers and Restraints

The demand for extracorporeal blood treatment is expected to upsurge owing to the growth of kidney diseases. The demand for kidney dialysis has increased as the prevalence of chronic conditions such as hypertension, heart diseases and diabetes are on a rise along with the elderly population. International statistics has shown that as compared to other advanced countries such as Japan, U.S. has a higher rate of dialysis utilization. In 1960, the first dialysis center was started and the establishment of Medicare’s End Stage Renal Disease Program ensured the coverage of expensive dialysis treatment. From its establishment in 1973, around 400,000 people have received dialysis under the Medicare’s End Stage Renal Disease Program.

Extracorporeal Blood Treatment Market: Overview

Extracorporeal blood treatment is a purification process that takes place outside the body. The blood passes through the membrane, filters the waste or molecules within the extracorporeal region and returning to normal state. Purified blood is then returned back to the patient’s body suffering from kidney injury.

The growth of the dialysis facilities in the U.S. has increased by 6% annually over the past five years. There has been an increase in the population of U.S. diagnosed with end-stage renal disease.

According to the data provided by the U.S. Renal Data System, in 2013 the number of patient who underwent dialysis were 468,000. The 47 fold increase in the dialysis procedure in the past 40 years is driven by the rise in diabetes and other chronic conditions.

Extracorporeal Blood Treatment Market: Region-wise Outlook

In terms of geography, extracorporeal blood treatment market has been divided into five regions including North- America, Asia- Pacific, Middle-East & Africa, Latin America and Europe. North America region dominated the extracorporeal blood treatment market owing to the presence of undisputed market players, the presence of strong research developments and presence of insurance coverage. For instance, Baxter presented their study on the role of extracorporeal blood purification in the removal of molecules which leads to inflammation. Economically developing region such as Asia Pacific is expected to be the fastest growing with the presence of huge population base and also an increase in the number of patient undergoing dialysis.

To view TOC of this report is available upon request @ www.persistencemarketresearch.com/toc/15685

Extracorporeal Blood Treatment Market: Key Market Participants

Some of the extracorporeal blood treatment market participants are Fresenius Medical Care N.A., DaVita Kidney Care, U.S. Renal Care, Dialysis Clinic Inc., American Renal Associates, Satellite Healthcare, Atlantic Dialysis Management, Northwest Kidney Centers, Centers for Dialyssis Care and Rogosin Institute.

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us

Persistence Market Research

305 Broadway

7th Floor, New York City,

NY 10007, United States,

USA – Canada Toll Free: 800-961-0353

Email: sales@persistencemarketresearch.com

Web: http://www.persistencemarketresearch.com

Global Veterinary Teleradiology Market to Surge at a Robust Pace in Terms of Revenue Over 2017 – 2025

Veterinary teleradiology is the practice of medical images interpretation and analysis by a radiologist who is not present at the site where the images were generated. This market is utilized by hospitals, pet clinics, and veterinary radiology centers. Teleradiology enables radiologists to use advanced teleradiology solutions in order to improve patients care and treatment without any delay in the treatment process. The concept of teleradiology arose due to dearth of radiologists, as the specialized group of people is generally located in metropolitan areas. Teleradiology markets enable trained specialists to provide their interpretation and guidance 24/7 across the globe.

A Sample of this Report is Available Upon Request @  http://www.persistencemarketresearch.com/samples/15628

The primary factor fuelling demand for teleradiology market is increasing domestic, livestock and companion animal industry, rising animal disease and accidental cases, growing number of veterinary practitioners and the income levels. In addition rising innovations in teleradiology services, which offer rapid and accurate results to customers.  However, a primary factor hampering growth of the teleradiology market is the risk of data security, high cost of technology, dearth of trained radiologists and technicians and transformation access to remote areas.

High cost of services, image transmission issues, low awareness in emerging economies are going to be a major challenge for veterinary teleradiology services market. Manufacturers are expected to invest more on the product technology for quick transformation of data which include various parameters of information and technology. Ongoing trends for teleradiology services are driving the whole market coupled with the latest IT infrastructure which also include artificial intelligence and algorithms, cloud with low maintenance and image backup storage.

The global market for veterinary teleradiology is segmented on basis of product type, construction material, end user and geography:

Segmentation by Service Type

Emergency Care, Day Time Coverage, Second Opinion, Sub-specialty Reading

Segmentation by Modality Material

X-ray, Computerized Tomography (CT) Scan, Magnetic Resonance Imaging (MRI), Ultrasound Scans, Nuclear Scan

Segmentation by End User

Hospitals, Pet Clinics, Veterinary Radiology Centers

Based on services type, the market has been segmented into emergency care, day time coverage, subspecialty reading, and second opinion. Day care and emergency care dominates the global veterinary teleradiology services market and is expected to do so throughout the forecast period. This service type segment is anticipated to expand with the fastest CAGR over the forecast period.

Based on modality type, the market is segmented into X-Ray Scans, CT Scans, MRI Scans, Ultrasound Scans, Nuclear Scan, and Others. In terms of revenue share, CT scans dominated the veterinary teleradiology Market owing to increase in CT scans in the region is projected to do so throughout the forecast period. However, MRI scans are projected to grow with high CAGR than other modalities over the forecast period.

Based on end user, the global veterinary teleradiology market has been segmented into hospitals, pet clinics and veterinary radiology centers. Hospitals are expected to contribute highest share in the global veterinary teleradiology market over the forecast period.

On the basis of regional presence, global veterinary teleradiology market is segmented into five key regions namely North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America is expected to lead the global market due to large number of pet adoption, increasing disease and accidental cases in pet animals, and growing expenditure on animal healthcare, while Europe is expected to hold second largest market share in the global market. Market in Asia-Pacific region is expected to witness significant growth rate over the forecast period owing to growing trend of pet adoption and increasing focus on teleradiology services.

Some of the players operating in global veterinary teleradiology market are VetCT, Veterinary Imaging Consultations, Inc., Lynks Group, Animal Imaging Consultants, Vet-Rad LTD, Veterinary Medical Centers, and PetRays among others.

To view TOC of this report is available upon request @ http://www.persistencemarketresearch.com/toc/15628

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

 

Global Immunoassay Systems Market to Register Steady Growth During 2017 – 2025

Immunoassay has become essential laboratory technique that can be used to measure concentration of different analytes. Immunoassay systems are thus essentially adopted by virtually all the diagnostic laboratories, academic and research institutes, hospital diagnostic centers and other potential end users. Introduction of multiplex immunoassays has further expanded the applications of immunoassay systems in different industries such as pharmaceutical companies, biotechnology and life science industries, food and beverage industries, environment control measurements etc. Modern immunoassays employ labeling techniques such as enzyme labeled, radiolabelled, chromophore labelled, fluorescence labelled etc. and immunoassay systems are used to detect these labelled analytes qualitatively or quantitatively. Some of the established brands in global immunoassay systems include ADVIA (Siemens), UniCel DxI (Beckman Coulter), IDS-iSYS (Immunodiagnostic Systems Inc.), LUMINEX (Luminex Corporation), Cobas Analyzer (Roche) etc. among others. Companies offering multiplex immunoassay systems are expanding their efficiency of multiplexing which is expected to boost the demand for these devices over time. These established brands are benefited with customer loyalty and high cost of instrument switching.

A Sample of this Report is Available Upon Request @  http://www.persistencemarketresearch.com/samples/15613

The global market for immunoassay systems is expected to be driven by adoption of immunoassay systems by academic and research institutes in U.S. and Europe. Moreover, continuous increase in R&D expenditures and increasing research grants and government funding to research laboratories would further increase the demand for immunoassay systems. Growing automation in diagnostic laboratories would demand the more use of automated immunoassay systems in order to fulfil the need for performing more in less cost. Recent advancements in multiples immunoassay and expansion of its applications in veterinary diagnostics and food contamination testing would expand the install base of immunoassay systems in these industries. However, stringent regulatory requirements and frequent recalls of immunoassay systems is the major factor limiting the growth of global immunoassay systems market. For instance, recently in July 2016, FDA announced recall of ADVIA Centaur XPT system due to defective results generated by system software.

In recent there has not been much innovation in the immunoassay systems technology. However, manufacturers of immunoassay systems are cross collaborating with developers of immunoassay kits and reagents. Moreover, manufacturers who provide immunoassay kits and reagents for their own system are focusing to launch new or improved immunoassay kits in order to ensure the continuation of services and customer retention for already installed immunoassay systems.

The global market for immunoassay systems is segmented on basis of product type, technology, end user and geography:

Segmentation by Product Type

Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Nephelometric Immunoassay Systems, Radio Immunoassay Systems, Others

Segmentation by Technology

Single Plex Immunoassay Systems, Multiplex Immunoassay Systems

Segmentation by End User

Diagnostic Centers, Pharmaceutical Companies, Academic and Research Institutes, Government Agencies, Others

Based on product type, fluorescence and chemluminescence immunoassay systems collectively contributed highest share in global immunoassay systems market so far. Based on end user, global immunoassay systems market has been segmented into diagnostic centers, pharmaceutical companies, academic and research institutes, government agencies and others. Diagnostic laboratories and pharmaceutical companies contribute highest share in global immunoassay systems maret.

Regionally, global immunoassay systems market is segmented into five key regions viz. North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America clearly dominates the global market for immunoassay systems due to huge install base and growing adoption of these systems in academics and research institutes. Europe is expected to be the second largest market for immunoassay systems owing to consolidation of immunoassay system providers and manufacturers in the region in recent years. Asia pacific immunoassay systems market is expected to witness impressive growth rate over the forecast period of 2017–2025, primarily due to high demand for immunoassay systems in Japan and Australia.

To view TOC of this report is available upon request @ http://www.persistencemarketresearch.com/toc/15613

Some of the players identified in global immunoassay systems market include Siemens Healthcare Private Limited, Beckman Coulter, Inc. (Danaher Corporation), Thermo Fisher Scientific Inc., Promega Corporation, Immunodiagnostic Systems Inc., Bio Rad Laboratories Inc., EMD Millipore (Merck KGaA), F. Hoffmann-La Roche Ltd. etc. among others. All the companies operating in immunoassay systems market also provide immunoassay kits and reagents specific to their systems. Major players are trying to maximize their install base for immunoassay systems on the basis of long term contracts with the end customer to purchase reagents and kits specific to their immunoassay system.

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us

Persistence Market Research

305 Broadway

7th Floor, New York City,

NY 10007, United States,

USA – Canada Toll Free: 800-961-0353

Email: sales@persistencemarketresearch.com

Web: http://www.persistencemarketresearch.com